Vaccine News and Research

Latest Vaccine News and Research

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Research reports the results of a phase 3 clinical trial evaluating the safety, immunogenicity, and efficacy of the NVX-CoV2373 vaccine in adolescents aged 12 to 17 years. The study found that the vaccine was safe, immunogenic, and efficacious in preventing COVID-19, including the Delta variant, in adolescents.

27 Apr 2023

Molnupiravir treatment reduces risk of long COVID in high risk patients

Among high-risk individuals, molnupiravir treatment in the acute phase of infection could prevent long COVID.

27 Apr 2023

Developing Next-Generation Nanomaterials for Medical Applications

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Dr. Chad Merkin, Director of the International Institute for Nanotechnology, about his work developing next-generation nanomaterials for medical applications.

From Pittcon 27 Apr 2023

Research identifies Th1 memory CD4+ T cells as key to protect against emerging poxvirus skin infections

Researchers demonstrate that T helper 1 effector memory cluster of differentiation 4 T cells provide immunity against poxviruses

27 Apr 2023

Neurological phenotypes induced by SARS-CoV-2 spike protein in neurons

Researchers explored the association between SARS-CoV-2 spike protein and burst activities in neurons.

27 Apr 2023

Research uncovers antibodies that are still effective against new variants of SARS-CoV-2

An anonymous San Diego resident has become a fascinating example of how the human immune system fights SARS-CoV-2.

26 Apr 2023

Understanding the cervical microbiome: a promising frontier in HPV treatment

A recent feature published in PNAS provided emerging insights into microflora associated with human papillomavirus (HPV) infections.

26 Apr 2023

Print your own vaccine: automatic printing of microneedle patch COVID-19 mRNA vaccines

Researchers reported on the automatic printing of microneedle patch SARS-CoV-2 mRNA vaccines.

26 Apr 2023

Study reveals survival time of SARS-CoV-2 in wastewater: Implications for public health

Study investigated the survival of SARS-CoV-2 in three wastewater matrices - filtered and unfiltered raw wastewater, and secondary effluent. The time required for inactivation of 90% of SARS-CoV-2 was observed to be 10.4, 10.8, and 18.3 hours for unfiltered raw, filtered raw, and secondary effluent, respectively.

25 Apr 2023

The Wonder of DNA: Reflections from Dr. Francis Collins on the 20th Anniversary of the Human Genome Project

To highlight how far the field of genetics has come, we spoke with Dr. Francis Collins, the leader of the Human Genome Project about his incredible career in genetics.

25 Apr 2023

A mobile vaccine printer could enable rapid vaccination of large numbers of people

Getting vaccines to people who need them isn't always easy. Many vaccines require cold storage, making it difficult to ship them to remote areas that don't have the necessary infrastructure.

24 Apr 2023

RSV infection in the first year of life associated with increased risk of childhood asthma

Severe respiratory syncytial virus (RSV) infection has long been associated with the onset of childhood wheezing diseases, but the relationship between RSV infection during infancy and the development of childhood asthma has remained unclear.

24 Apr 2023

What are the trends in severe outcomes among patients hospitalized with COVID-19 during the first 2 years of the COVID-19 pandemic?

Researchers documented surveillance across a network of 155 acute care hospitals in Canada between March 15, 2020, and May 28, 2022.

24 Apr 2023

Deciphering immunological imprinting in the context of COVID-19

In a recent article published in the journal Immunity, researchers explained the concept of immunological imprinting and its underlying principles. They also discussed its potential role in the context of coronavirus disease 2019 (COVID-19) vaccines.

24 Apr 2023

Visual narratives emphasizing communal benefits boost COVID-19 vaccination rates

In a recent study published in the journal PNAS Nexus, researchers performed a three-wave online panel survey across 50 states in the United States of America (USA) and Washington D.C. in 2021 to test the influence of visual narrative-based policy communication messages on people's attitudes and behavior towards coronavirus disease 2019 (COVID-19) and benefits of COVID-19 vaccination.

23 Apr 2023

Novel self-amplifying RNA vaccine confers durable protection against COVID-19, reduces viral shedding in primate study

A self-amplifying replicon RNA vaccine against SARS-CoV-2 can elicit durable and protective immunity in pigtail macaques, even after neutralizing antibody responses have waned to undetectable levels.

23 Apr 2023

Study reveals alarming global burden of antimicrobial resistance in bacterial infections

The paper presents a systematic analysis of the global burden of bacterial antimicrobial resistance in 2019. The authors highlight the urgent need for action to address this growing public health threat.

23 Apr 2023

Large-scale study identifies factors linked to uptake of first COVID-19 vaccination dose

A large-scale registry study in Finland has identified several factors associated with uptake of the first dose of COVID-19 vaccination. In particular, persons with low or no labor income and persons with mental health or substance abuse issues were less likely to vaccinate.

21 Apr 2023

Gut bacteria could be responsible for dampening our immune response to COVID-19 vaccine

Gut bacteria that break down a sugar called fucose could be dampening our immune response to the COVID-19 mRNA vaccine, according to a study led by researchers from the Okinawa Institute of Science and Technology.

20 Apr 2023

Omicron spike N679K mutation acts as a loss-of-function mutation attenuating SARS-CoV-2 in vitro & in vivo

Researchers explored the impact of a loss-of-function mutation in the SARS-CoV-2 Omicron variants on the expression of the spike protein.

20 Apr 2023

Previous
1
...
77
78
79
80
81
82
83
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Molnupiravir treatment reduces risk of long COVID in high risk patients

Developing Next-Generation Nanomaterials for Medical Applications

Research identifies Th1 memory CD4+ T cells as key to protect against emerging poxvirus skin infections

Neurological phenotypes induced by SARS-CoV-2 spike protein in neurons

Research uncovers antibodies that are still effective against new variants of SARS-CoV-2

Understanding the cervical microbiome: a promising frontier in HPV treatment

Print your own vaccine: automatic printing of microneedle patch COVID-19 mRNA vaccines

Study reveals survival time of SARS-CoV-2 in wastewater: Implications for public health

The Wonder of DNA: Reflections from Dr. Francis Collins on the 20th Anniversary of the Human Genome Project

A mobile vaccine printer could enable rapid vaccination of large numbers of people

RSV infection in the first year of life associated with increased risk of childhood asthma

What are the trends in severe outcomes among patients hospitalized with COVID-19 during the first 2 years of the COVID-19 pandemic?

Deciphering immunological imprinting in the context of COVID-19

Visual narratives emphasizing communal benefits boost COVID-19 vaccination rates

Novel self-amplifying RNA vaccine confers durable protection against COVID-19, reduces viral shedding in primate study

Study reveals alarming global burden of antimicrobial resistance in bacterial infections

Large-scale study identifies factors linked to uptake of first COVID-19 vaccination dose

Gut bacteria could be responsible for dampening our immune response to COVID-19 vaccine

Omicron spike N679K mutation acts as a loss-of-function mutation attenuating SARS-CoV-2 in vitro & in vivo

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in